A detailed history of High Tower Advisors, LLC transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 10,003 shares of TMCI stock, worth $75,922. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,003
Holding current value
$75,922
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.01 - $8.45 $50,115 - $84,525
10,003 New
10,003 $58,000
Q3 2023

Nov 08, 2023

BUY
$12.16 - $24.87 $60,106 - $122,932
4,943 Added 57.53%
13,535 $177,000
Q2 2023

Aug 14, 2023

BUY
$23.91 - $27.81 $11,763 - $13,682
492 Added 6.07%
8,592 $219,000
Q1 2023

May 11, 2023

SELL
$20.23 - $26.22 $38,437 - $49,818
-1,900 Reduced 19.0%
8,100 $204,000
Q2 2021

Aug 06, 2021

BUY
$25.53 - $36.11 $255,300 - $361,100
10,000 New
10,000 $313,000

Others Institutions Holding TMCI

About TREACE MEDICAL CONCEPTS, INC.


  • Ticker TMCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 55,403,300
  • Market Cap $421M
  • Description
  • Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...
More about TMCI
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.